Home ASHP Midyear 2015
OVERVIEW
INVESTOR.SAGENTPHARMA.COM RANKINGS
Date Range
Date Range
Date Range
LINKS TO WEB SITE
VANCOMYCIN Hydrochloride for Injection, USP. GEMCITABINE for Injection, USP. COLISTIMETHATE for Injection, USP. UIC Chicago Area Entrepreneurship Hall of Fame. Sagent Pharmaceuticals Reports Second Quarter 2015 Financial Results. Sagent Pharmaceuticals Board Appoints Allan Oberman as Chief Executive Officer. Sagent Pharmaceuticals Reports First Quarter 2015 Financial Results.
WHAT DOES INVESTOR.SAGENTPHARMA.COM LOOK LIKE?
INVESTOR.SAGENTPHARMA.COM HOST
BROWSER ICON
SERVER OS
I discovered that investor.sagentpharma.com is employing the Apache/2.2.22 (Debian) server.PAGE TITLE
Home ASHP Midyear 2015DESCRIPTION
The SAGENT logo, SAGENT and SAGENT Pharmaceuticals are registered trademarks of Sagent Pharmaceuticals, Inc. Is a service mark of Sagent Pharmaceuticals, Inc. 2018 Sagent Pharmaceuticals, Inc.CONTENT
This domain states the following, "The SAGENT logo, SAGENT and SAGENT Pharmaceuticals are registered trademarks of Sagent Pharmaceuticals, Inc." We observed that the web page also said " Is a service mark of Sagent Pharmaceuticals, Inc." It also stated " 2018 Sagent Pharmaceuticals, Inc."SEEK MORE WEB PAGES
Sally Beauty Holdings, Inc. Announces Fiscal 2015 Third Quarter Results. Beauty is in the eye of the shareholder. An open-line and exclusive-label beauty products retailer offering professional beauty products to both retail consumers and salon professionals. Multi-channel Platform with Differentiated Value Proposition.
Q2 2015 Sanchez Energy Corp Earnings Conference Call. Q2 2015 Sanchez Energy Corp Earnings Conference Call. Click here to add this event to your calendar. Sanchez Energy Corporation Adopts Rights Plan to Protect Net Operating Loss Carryforwards. Reports Record Production of 53,920 B.
Up to 10x faster than HDD. Find out more about how SanDisk is expanding the possibilities of storage technology. From individuals to consumers to OEMs, SanDisk continues to make data storage more reliable, and cost-effective.
Stock Snapshot View Detailed Stock Info. Sangamo Therapeutics Announces Presentations At Upcoming Investor Conferences. Authorization Of Clinical Trial Evaluating Zinc Finger Nuclease In Vivo Genome Editing Treatment For Hemophilia B. Fiscal Year Ended Dec 31, 2017.
Sapient Global Markets Survey Reveals Escalating Trade Reporting Costs and Concerns over Maintaining Compliance. The Community at SapientNitro Awarded Press Grand Prix at 62nd Annual Cannes Lions Festival of Creativity.